Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
11.78
+0.15 (1.29%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Design Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $21. The average 1-year stock price forecast is 78.27% higher than the current stock price, while the lowest is $20 (+69.78%) and the highest is $22 (+86.76%).
Price Target: $21 (+78.27%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 15, 2026.
Analyst Ratings
The average analyst rating for Design Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +78.27% | Jun 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +69.78% | May 27, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $22 | Buy | Reiterates | $22 | +86.76% | May 19, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +69.78% | May 18, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.36
from -1.22
EPS Next Year
-1.64
from -1.36
EPS and Forward PE are based on non-GAAP adjusted numbers.